Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Gujrat Based Shalby...

    Gujrat Based Shalby Hospitals eyes IPO, filed draft herring prospectus with SEBI

    Written by Ruby Khatun Khatun Published On 2017-05-23T13:49:50+05:30  |  Updated On 23 May 2017 1:49 PM IST
    Gujrat Based Shalby Hospitals eyes IPO, filed draft herring prospectus with SEBI

    Gujrat: The Ahmedabad based Super-Specialty hospital chain, Shalby Hospitals is soon aiming towards an Initial Public Offer (IPO) for listing its shares on the stock market. It is reported that for the same a draft red herring prospectus (DRHP) was recently filed by Shalby Hospitals, with the Securities and Exchange Board of India (SEBI).


    As per recent media reports,the public issue will comprise fresh sale of shares worth Rs 580 crore besides an offer for sale of 1 million shares by promoter Vikram Shah.


    VC circle reports that the estimated size of total issue worth Rs 600-620 crore ($97 million) will result in dilution of 15-18% of stake on post-offer basis.The promoter currently owns 9.85% stake in Shalby, which is it assumed shall reduce to roughly 7.5% post-offer. With these numbers, the post offer value of the hospital chain would stand at roughly Rs 4100 crore.


    The proceeds shall be directed towards repaying the borrowings besides upgrading the existing facilities and setting up new hospitals. The company's total debt stood at Rs 70.27 crore as on 31 December 2016, the DRHP showed. The daily adds that Shalby may focus on expansion in west and central India, including in cities such as Ranchi, Bhopal and Pune


    In February 2016, Shalby had signed a joint venture with Dubai-based RAK Hospitals for joint replacement surgeries.


    Shalby Hospitals was founded in 1993 and has a chain of 11 hospitals, including eight fully operational and three recently set-up hospitals. It had an aggregate bed capacity of 2,102 beds as on 31 March 2017, according to DRHP and was aiming to cross 2,500 beds by the end of 2017, according to its website. Besides other specialties, the hospitals conducts around 8,000 joint replacement surgeries in a year. half of its revenues come from hip and knee joint replacement surgeries.According to a Frost & Sullivan report the hospital chain enjoyed a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016.


    Aster DM HealthcareDraft Red Herring ProspectusHealthCare Global Enterprises Ltdinitial public offeringIPORavi Bhandarisale of sharesSEBISecurities and Exchange Board of IndiashalbyShalby HospitalsSharesVikram I Shah
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok